Education
About Us
Working with TipRanks
Follow Us
MediNice SA (PL:ICE)
:ICE
ICE Stock Chart & Stats
Day’s Range― - ―
52-Week Rangezł6.74 - zł13.80
Previous CloseN/A
VolumeN/A
Average Volume (3M)60.11K
Market Cap
zł93.58M
Enterprise ValueN/A
Total Cash (Recent Filing)zł2.54M
Total Debt (Recent Filing)zł275.00K
Price to Earnings (P/E)2.2
Beta0.13
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding7,695,648
10 Day Avg. Volume41,283
30 Day Avg. Volume60,111
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.64
Price to Sales (P/S)277.23
P/FCF Ratio-14.25
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
ICE FAQ
What was MediNice SA’s price range in the past 12 months?
MediNice SA lowest stock price was zł6.74 and its highest was zł13.80 in the past 12 months.
What is MediNice SA’s market cap?
MediNice SA’s market cap is zł93.58M.
When is MediNice SA’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were MediNice SA’s earnings last quarter?
Currently, no data Available
Is MediNice SA overvalued?
According to Wall Street analysts MediNice SA’s price is currently Overvalued.
Does MediNice SA pay dividends?
MediNice SA does not currently pay dividends.
What is MediNice SA’s EPS estimate?
MediNice SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does MediNice SA have?
MediNice SA has 7,695,648 shares outstanding.
What happened to MediNice SA’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of MediNice SA?
Currently, no hedge funds are holding shares in PL:ICE
Company Description
MediNice SA
Medinice S.A. provides medical solution for cardiology and cardiac surgery. The company support scientists for product commercialization including prototyping, clinical trials and certification, and product sales. Medinice S.A. was founded in 2012 and is based in Warsaw, Poland.